Sarah N. Dumont
Villejuif, 94805, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Transitioning to adult oncology for adolescents and young adults (AYAs): The experience of an AYA unit
Journal: Medecine sciences : M/S
Published: September 08, 2025
Impact of nurse navigation and mobile app on brain tumor patients receiving oral anticancer therapy.
Impact of nurse navigation and mobile app on brain tumor patients receiving oral anticancer therapy.
Journal: NPJ digital medicine
Published: July 23, 2025
Proton therapy for adult type IDH-mutated glioma: Proglio-1, a multicenter retrospective study.
Journal: Radiation oncology (London, England)
Published: May 19, 2025
Real life data of ONC201 (dordaviprone) in pediatric and adult H3K27-altered recurrent diffuse midline glioma: Results of an international academia-driven compassionate use program.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 22, 2024
Implementation of a multimodal strategy for information and collection of advance directives in a comprehensive cancer center
Journal: Bulletin du cancer
Published: January 09, 2023
Contribution of collegial support meetings (CSM) in the management of complex situations of patients with advanced cancer.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: January 02, 2023
Erratum to "Sarcome avec transcrit de fusion EWSR1-PATZ1 Une nouvelle observation avec revue de la littérature" [Ann. Pathol. 41 (2021) 207-211/1513].
Journal: Annales de pathologie
Published: August 23, 2022
Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?
Journal: Journal of neurology
Published: June 20, 2022
Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 24, 2021
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).
Journal: Neuro-oncology
Published: October 21, 2021
Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial.
Journal: Nature medicine
Published: October 07, 2021
Last Updated: 09/26/2026